Asia Pacific Glucose Monitoring Devices Market

The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It is estimated to grow at a CAGR of 12.1% from 2022 to 2030.   

Growing Geriatric Population Fuel Asia Pacific Glucose Monitoring Devices Market

Diabetes among the geriatric population is a growing public health burden worldwide. It is a major cause of morbidity and mortality in the aging population that is later largely attributable to various chronic complications. The aging population is poised to become one of the most significant transformations with a heavy impact on the global social and economic level. This population is growing exponentially worldwide. According to the World Health Organization (2022), by 2030, 1 in 6 people will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 or older is expected to triple between 2020 and 2050 to reach 426 million. The number of geriatric populations is expected to grow significantly in Africa, followed by Asia Pacific. Elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly serious in this population. With the increase in the geriatric population, the prevalence of diabetes has increased. Therefore, there is notable demand for glucose monitoring devices.

Asia Pacific Glucose Monitoring Devices Market Overview

The Asia Pacific Glucose Monitoring Devices Market has been segmented into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the diabetes diagnosis. India holds second largest share in terms of continuous glucose monitoring owing to high prevalence of diabetes in the country. The aforementioned factors are responsible for influential growth of Asia Pacific Glucose Monitoring Devices Market in the Asia Pacific region.

Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Glucose Monitoring Devices Market Segmentation

The Asia Pacific glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the Asia Pacific glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on application, the Asia Pacific glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on testing site, the Asia Pacific glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on end user, the Asia Pacific glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on country, the Asia Pacific glucose monitoring devices market is segmented into the China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. China dominated the Asia Pacific glucose monitoring devices market in 2022.   

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Asia Pacific glucose monitoring devices market. 

Asia Pacific Glucose Monitoring Devices Strategic Insights

Strategic insights for the Asia Pacific Glucose Monitoring Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Glucose Monitoring Devices Report Scope

Asia Pacific Glucose Monitoring Devices Regional Insights

The geographic scope of the Asia Pacific Glucose Monitoring Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.